• Nenhum resultado encontrado

Epigenetic Modifications: Therapeutic Potential in Cancer

N/A
N/A
Protected

Academic year: 2019

Share "Epigenetic Modifications: Therapeutic Potential in Cancer"

Copied!
14
0
0

Texto

Loading

Imagem

Figure  1  -  Methylation  pattern  in  normal  and  tumor  state.  Hypo-  and  hypermethylation  in  the  promoter  leads  to  disease  in  the  cell
Table 1 - Classification table for HDAC.
Table 2 - Classification of DNMT inhibitors.
Table 3 - List of HDACs in clinical trials.
+3

Referências

Documentos relacionados

The present study retrospectively in- cluded 25 patients with breast cancer un- der tamoxifen therapy referred to the De- partment of Ultrasound at Hospital das Clínicas da

Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III,

Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer

Phase 2 randomized trial of primary endocrine therapy versus chemo- therapy in postmenopausal patients with estrogen receptor- positive breast cancer. Chemotherapy (CT)

Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients

To analyze the accuracy of the defining features of ND for fatigue in patients with breast cancer under radiation therapy

A Estrutura Simples e os modelos de negócio que caracterizam as estruturas da Comunicação Web, das Reuniões Virtuais e dos Eventos apresentam uma relação em dois pontos: (1) Por